SCHEMBL9998598

SCHEMBL9998598

CCCC(=Cc1ccccc1F)C(OC(C)=O)OC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.43
CYP2C19 P33261 3/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
TRPA1 O75762 1/20 0.43
HIF1A Q16665 1/20 0.43
RAB9A P51151 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.38
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998597 1.00 CYP1A2 (0.43) CYP1A2CYP2C19CYP3A4CYP2C9TRPA1
SCHEMBL9998101 0.89 TRPA1 (0.48) CYP1A2CYP2C19CYP3A4CYP2C9TRPA1
SCHEMBL9998103 0.89 TRPA1 (0.48) CYP1A2CYP2C19CYP3A4CYP2C9TRPA1
SCHEMBL9997239 0.84 CYP1A2 (0.35) CYP1A2CYP2C19CYP3A4CYP2C9ALDH1A1
SCHEMBL9997714 0.84 P2RX7 (0.37) CYP1A2CYP3A4ALDH1A1SMN1; SMN2GAA
SCHEMBL9997719 0.84 P2RX7 (0.37) CYP1A2CYP3A4ALDH1A1SMN1; SMN2GAA
SCHEMBL9997241 0.84 CYP1A2 (0.35) CYP1A2CYP2C19CYP3A4CYP2C9ALDH1A1
SCHEMBL9998127 0.83 POLB (0.38) CYP1A2CYP2C19CYP3A4CYP2C9ALDH1A1
SCHEMBL9998020 0.83 NLRP3 (0.33) CYP1A2CYP3A4L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL9998125 0.83 POLB (0.38) CYP1A2CYP2C19CYP3A4CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP1A2 19/4885CYP2C19 85/4885CYP3A4 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.